Reimbursed Care Access in Guinea

Currently classified as a strictly controlled substance under Guinea's drug laws with no authorized medical use outside of approved clinical research. The Guinean Penal Code criminalizes use, possession, cultivation and trafficking of controlled psychotropic substances and adopts the list of controlled substances from international conventions, creating statutory penalties for illicit activities related to such substances #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Guinea's penal code contains broad prohibitions and penalties for drugs and psychotropics and implements control consistent with international drug conventions, which govern MDMA-type substances. There is no public record of MDMA being authorized for clinical therapeutic programmes or reimbursement in Guinea #.

No evidence was found of national regulatory approval, formal availability, or public reimbursement of esketamine (Spravato) for depression in Guinea. Guinea's medicines law requires ministerial/decreed authorizations and states that the Republic adopts lists of controlled substances based on ratified international conventions and that imports/dispensation of narcotics/psychotropics require specific ministerial authorization, which makes market entry and reimbursement contingent on national approval processes #. There is no listing of esketamine on the WHO Model List of Essential Medicines, and there are no publicly available Guinean regulatory entries indicating Spravato approval or inclusion in public insurance formularies.

Ketamine is an established and widely used injectable anesthetic in Guinea's clinical practice and is included on the WHO Model List of Essential Medicines, supporting its accepted medical use for anesthesia and emergency care #. Studies of anesthesia practice in Conakry and other Guinean hospitals document routine clinical use of ketamine for operative and emergency anaesthesia in public hospitals, indicating availability in the health system (though this does not imply formal national reimbursement for non-hospital uses). For example, an observational study of hospitals in Conakry lists ketamine among the most frequently used anesthesia products in routine care #. Guinea’s medicines law requires ministerial authorization and inspection for importation, prescription and dispensation of narcotics and psychotropic preparations; reimbursement arrangements depend on national policy and there is no published evidence that Guinea operates a centralized public reimbursement programme for ketamine-based mental health indications (ketamine use in Guinea is principally as an anesthetic within hospitals) #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Guinea's Penal Code criminalizes unauthorized possession and trafficking of psychotropic substances and adopts international control lists, which would encompass DMT-type substances; there is no public record of medicinal authorisation or reimbursement for DMT in Guinea #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no evidence of legal medical pathways, registration, or reimbursement for 5‑MeO‑DMT in Guinea; the Penal Code and medicines law provide the legal basis for criminalization and ministerial control of psychotropics. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Guinea’s drug-control framework criminalizes unauthorized use, possession and distribution of psychotropic substances; there is no public evidence of authorized medical programmes or reimbursement for ibogaine. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Traditional or religious use of plant-based psychedelic brews is not legally authorized if they contain scheduled psychotropic compounds; possession, preparation or distribution of scheduled substances is subject to penalties under the Penal Code. There is no public evidence of legal frameworks permitting ayahuasca ceremonies or health-system reimbursement in Guinea. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Guinea’s adoption of international control lists and domestic penal provisions means mescaline-containing cacti preparations are not legally authorized for therapeutic or recreational use; no national medicinal authorisation or reimbursement was identified. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Guinea’s criminal code and drug-control legislation include broad definitions and penalties covering novel synthetic psychotropics and analogues; no legal medical access or reimbursement pathways for 2C-series compounds were identified. #